Raleigh, NC, United States of America

Viteros Wiltshire-Lyerly


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Viteros Wiltshire-Lyerly: Innovator in Prion Protein Binding Technologies

Introduction

Viteros Wiltshire-Lyerly is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of materials and methods for detecting prion proteins. His innovative work has implications for both medical diagnostics and environmental safety.

Latest Patents

Wiltshire-Lyerly holds a patent for "Prion protein binding materials and methods of use." This patent describes materials designed to detect or remove prion proteins from various samples, including biological fluids and environmental samples. The binding materials are effective in binding to multiple forms of prion proteins, such as cellular prion protein (PrPc), infectious prion protein (PrPsc), recombinant prion protein (PrPr), and proteinase resistant prion protein (PrPres). His technology is capable of binding prions from various species, including humans and hamsters.

Career Highlights

Throughout his career, Wiltshire-Lyerly has worked with several organizations, including Pathogen Removal and Diagnostic Technologies Inc. and North Carolina State University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Some of his notable coworkers include Ruben Guillermo Carbonell and Honglue Shen. Their collaborative efforts have furthered research in prion protein detection and removal technologies.

Conclusion

Viteros Wiltshire-Lyerly's work in prion protein binding technologies showcases his innovative spirit and dedication to advancing biotechnology. His contributions are vital for improving diagnostic methods and ensuring safety in various applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…